Santiago M. F.
- Country
- Spain
- Department
- Rheumatology
Research Overview
- Efficacy and Safety of Subcutaneous Anifrolumab in Adults with Moderate-to-Severe Systemic Lupus Erythematosus: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study
- Efficacy and Safety of Methotrexate, Methotrexate Disodium, and Adalimumab in Non-Infectious Non-Anterior Uveitis: A Phase 3 Randomized Study
Data & Insights
Has run more than one trial at 3 of 55 partner sites.
Specializations
Autoimmune Disorders
The investigator specializes in treating Systemic Lupus Erythematosus (SLE), with particular focus on moderate to severe manifestations of the condition. Their research interest encompasses innovative therapeutic approaches for managing this complex autoimmune disease.
- Systemic Lupus Management
- Novel Therapeutic Applications
- Disease Activity Assessment
Their work contributes to advancing treatment options for patients with challenging presentations of SLE.
Ophthalmology
The investigator focuses on treating non-infectious uveitis, particularly non-anterior forms of the condition. Their expertise extends to combination therapy approaches in inflammatory eye conditions.
- Non-Anterior Uveitis Treatment
- Combination Therapy Evaluation
- Long-term Disease Management
Their research explores treatment efficacy and cost-effectiveness in managing complex ocular inflammatory conditions.
Therapeutic Innovation
The investigator's work encompasses immunomodulatory treatments across multiple therapeutic areas. Their research focuses on evaluating both established and emerging treatment protocols.
- Clinical Response Assessment
- Treatment Optimization
- Therapeutic Monitoring
Their approach integrates assessment of treatment efficacy across extended observation periods.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.